A response-adjusted PET-based transplantation strategy in primary resistant and relapsed Hodgkin Lymphoma

Leukemia. 2013 Jun;27(6):1419-22. doi: 10.1038/leu.2012.318. Epub 2012 Nov 8.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Female
  • Fluorodeoxyglucose F18
  • Hodgkin Disease / surgery*
  • Humans
  • Male
  • Middle Aged
  • Positron-Emission Tomography*
  • Recurrence
  • Stem Cell Transplantation*
  • Treatment Outcome
  • Young Adult

Substances

  • Fluorodeoxyglucose F18